UrSure: the solution to HIV medication adherence



April 27, 2019

UrSure, Inc., is an HIV prevention startup based at Harvard University that makes diagnostic tests to measure and improve adherence for patients on PrEP for HIV prevention or medication for HIV treatment. We are collaborating with public health departments, researchers, and specialty HIV/AIDS clinics to use our novel, lab-based urine test to help reduce HIV incidence across the US. We are also developing a point-of-care version of our test that will come to market by early 2020.

Drug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.